Sotera Health [SHC] vs Revvity [RVTY] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Sotera Health Company wins in 9 metrics, Revvity Inc. wins in 11 metrics, with 0 ties. Revvity Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sotera Health Company | Revvity Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.70 | 45.77 | Revvity Inc. |
| Price-to-Book Ratio | 7.31 | 1.46 | Revvity Inc. |
| Debt-to-Equity Ratio | 375.56 | 46.87 | Revvity Inc. |
| PEG Ratio | 0.29 | 3.92 | Sotera Health Company |
| EV/EBITDA | 11.50 | 15.48 | Sotera Health Company |
| Profit Margin (TTM) | 6.70% | 8.45% | Revvity Inc. |
| Operating Margin (TTM) | 35.75% | 20.07% | Sotera Health Company |
| EBITDA Margin (TTM) | 35.75% | 20.07% | Sotera Health Company |
| Return on Equity | 15.42% | 3.22% | Sotera Health Company |
| Return on Assets (TTM) | 8.18% | 2.22% | Sotera Health Company |
| Free Cash Flow (TTM) | $149.18M | $509.41M | Revvity Inc. |
| Dividend Yield | N/A | 0.25% | N/A |
| 1-Year Return | 27.78% | 15.63% | Sotera Health Company |
| Price-to-Sales Ratio (TTM) | 3.82 | 3.69 | Revvity Inc. |
| Enterprise Value | $6.36B | $13.02B | Revvity Inc. |
| EV/Revenue Ratio | 5.47 | 4.56 | Revvity Inc. |
| Gross Profit Margin (TTM) | 54.68% | 54.62% | Sotera Health Company |
| Revenue per Share (TTM) | $4 | $25 | Revvity Inc. |
| Earnings per Share (Diluted) | $0.27 | $2.06 | Revvity Inc. |
| Beta (Stock Volatility) | 1.88 | 1.13 | Revvity Inc. |
| Short % of Float | 5.18% | 11.04% | Sotera Health Company |
Sotera Health Company vs Revvity Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sotera Health Company | 1.96% | -1.74% | -0.78% | -2.74% | -9.32% | -13.68% |
| Revvity Inc. | 1.32% | 4.42% | 16.83% | 5.34% | -2.12% | 2.98% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sotera Health Company | 27.78% | 5.89% | -37.69% | -37.69% | -37.69% | -37.69% |
| Revvity Inc. | 15.63% | -9.26% | -24.76% | 91.55% | 296.02% | 399.05% |
Performance & Financial Health Analysis: Sotera Health Company vs Revvity Inc.
| Metric | SHC | RVTY |
|---|---|---|
| Market Information | ||
| Market Cap | $4.44B | $9.74B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,339,870 | 860,236 |
| 90 Day Avg. Volume | 2,792,153 | 959,002 |
| Last Close | $15.57 | $102.40 |
| 52 Week Range | $10.80 - $19.85 | $81.22 - $118.30 |
| % from 52W High | -21.56% | -13.44% |
| All-Time High | $30.38 (Mar 15, 2021) | $203.16 (Dec 27, 2021) |
| % from All-Time High | -48.75% | -49.60% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.06% |
| Quarterly Earnings Growth | 1.83% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.08% |
| Operating Margin (TTM) | 0.36% | 0.20% |
| Return on Equity (TTM) | 0.15% | 0.03% |
| Debt to Equity (MRQ) | 375.56 | 46.87 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.13 | $64.57 |
| Cash per Share (MRQ) | $1.21 | $8.23 |
| Operating Cash Flow (TTM) | $287.20M | $582.93M |
| Levered Free Cash Flow (TTM) | $236.80M | $523.28M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.25% |
| Last 12-Month Dividend | N/A | $0.28 |
Valuation & Enterprise Metrics Analysis: Sotera Health Company vs Revvity Inc.
| Metric | SHC (Apr 26, 2026) | RVTY (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.70 | 45.77 |
| Forward P/E | 14.89 | 15.70 |
| PEG Ratio | 0.29 | 3.92 |
| Price to Sales (TTM) | 3.82 | 3.69 |
| Price to Book (MRQ) | 7.31 | 1.46 |
| Market Capitalization | ||
| Market Capitalization | $4.44B | $9.74B |
| Enterprise Value | $6.36B | $13.02B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.47 | 4.56 |
| Enterprise to EBITDA | 11.50 | 15.48 |
| Risk & Other Metrics | ||
| Beta | 1.88 | 1.13 |
| Book Value per Share (MRQ) | $2.13 | $64.57 |
Financial Statements Comparison: Sotera Health Company vs Revvity Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SHC (2025) | RVTY (2025) |
|---|---|---|
| Revenue/Sales | 1.16B | 2.86B |
| Cost of Goods Sold | 518.08M | 1.29B |
| COGS % of Revenue | 44.5% | 45.2% |
| Gross Profit | 645.53M | 1.56B |
| Gross Margin | 55.5% | 54.8% |
| Research & Development | N/A | 215.84M |
| Operating Income (EBIT) | 362.03M | 356.64M |
| Operating Margin | 31.1% | 12.5% |
| EBITDA | 507.29M | 792.21M |
| EBITDA Margin | 43.6% | 27.7% |
| Pre-Tax Income | 147.51M | 268.28M |
| Pre-Tax Income % of Revenue | 12.7% | 9.4% |
| Income Tax | 69.56M | 28.39M |
| Income Tax % of Revenue | 6.0% | 1.0% |
| Net Income (Profit) | 77.95M | 241.20M |
| Profit Margin | 6.7% | 8.4% |
Balance Sheet & Liquidity Metrics
| Metric | SHC (2025) | RVTY (2025) |
|---|---|---|
| Cash & Equivalents | 344.62M | 919.86M |
| Total Current Assets | 613.41M | 2.24B |
| Total Current Assets % of Revenue | 52.7% | 78.4% |
| Total Current Liabilities | 249.58M | 1.33B |
| Total Current Liabilities % of Revenue | 21.4% | 46.6% |
| Long-Term Debt | 2.25B | 2.78B |
| Long-Term Debt % of Revenue | 193.4% | 97.3% |
| Total Shareholders Equity | 606.04M | 7.25B |
| Retained Earnings | -532.09M | 6.05B |
| Retained Earnings % of Revenue | -45.7% | 212.0% |
| Property, Plant & Equipment | 41.32M | 165.44M |
Cash Flow Statement Comparison
| Metric | SHC (2025) | RVTY (2025) |
|---|---|---|
| Operating Cash Flow | 276.60M | 586.69M |
| Operating Cash Flow % of Revenue | 23.8% | 20.5% |
| Capital Expenditures | -138.02M | N/A |
| Free Cash Flow | 149.18M | 509.41M |
| FCF Margin | 12.8% | 17.8% |
| Debt Repayment | -86.10M | -521,000 |
| Common Stock Repurchase | N/A | -820.82M |
Short Interest & Institutional Ownership Analysis
| Metric | SHC | RVTY |
|---|---|---|
| Shares Short | 12.81M | 8.24M |
| Short Ratio | 4.40 | 7.79 |
| Short % of Float | 5.18% | 11.04% |
| Shares Outstanding | 284.37M | 112.28M |
| Float Shares | 191.73M | 102.65M |
| % Held by Insiders | 2.32% | 0.34% |
| % Held by Institutions | 85.40% | 103.68% |
| % Held by Public | 12.28% | -4.02% |
Dividend Analysis & Yield Comparison: Sotera Health Company vs Revvity Inc.
| Metric | SHC | RVTY |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.28 |
| Last 12-Month Dividend Yield | N/A | 0.25% |
| 3-Year Avg Annual Dividend | N/A | $0.28 |
| 3-Year Avg Dividend Yield | N/A | 0.06% |
| 3-Year Total Dividends | N/A | $0.84 |
| Ex-Dividend Date | N/A | Jan 16, 2026 |